These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 27191989)

  • 1. Proteomic analysis of stromal proteins in different stages of colorectal cancer establishes Tenascin-C as a stromal biomarker for colorectal cancer metastasis.
    Li M; Peng F; Li G; Fu Y; Huang Y; Chen Z; Chen Y
    Oncotarget; 2016 Jun; 7(24):37226-37237. PubMed ID: 27191989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissecting characteristics and dynamics of differentially expressed proteins during multistage carcinogenesis of human colorectal cancer.
    Peng F; Huang Y; Li MY; Li GQ; Huang HC; Guan R; Chen ZC; Liang SP; Chen YH
    World J Gastroenterol; 2016 May; 22(18):4515-28. PubMed ID: 27182161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tenascin C in colorectal cancer stroma is a predictive marker for liver metastasis and is a potent target of miR-198 as identified by microRNA analysis.
    Murakami T; Kikuchi H; Ishimatsu H; Iino I; Hirotsu A; Matsumoto T; Ozaki Y; Kawabata T; Hiramatsu Y; Ohta M; Kamiya K; Fukushima M; Baba S; Kitagawa K; Kitagawa M; Konno H
    Br J Cancer; 2017 Oct; 117(9):1360-1370. PubMed ID: 29065427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A quantitative proteomic approach of the different stages of colorectal cancer establishes OLFM4 as a new nonmetastatic tumor marker.
    Besson D; Pavageau AH; Valo I; Bourreau A; Bélanger A; Eymerit-Morin C; Moulière A; Chassevent A; Boisdron-Celle M; Morel A; Solassol J; Campone M; Gamelin E; Barré B; Coqueret O; Guette C
    Mol Cell Proteomics; 2011 Dec; 10(12):M111.009712. PubMed ID: 21986994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of stromal differentially expressed proteins in the colon carcinoma by quantitative proteomics.
    Mu Y; Chen Y; Zhang G; Zhan X; Li Y; Liu T; Li G; Li M; Xiao Z; Gong X; Chen Z
    Electrophoresis; 2013 Jun; 34(11):1679-92. PubMed ID: 23737015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-derived tenascin-C promotes the epithelial-mesenchymal transition in colorectal cancer cells.
    Takahashi Y; Sawada G; Kurashige J; Matsumura T; Uchi R; Ueo H; Ishibashi M; Takano Y; Akiyoshi S; Iwaya T; Eguchi H; Sudo T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
    Anticancer Res; 2013 May; 33(5):1927-34. PubMed ID: 23645740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics analysis of differential protein expression identifies heat shock protein 47 as a predictive marker for lymph node metastasis in patients with colorectal cancer.
    Mori K; Toiyama Y; Otake K; Fujikawa H; Saigusa S; Hiro J; Kobayashi M; Ohi M; Tanaka K; Inoue Y; Kobayashi Y; Kobayashi I; Mohri Y; Goel A; Kusunoki M
    Int J Cancer; 2017 Mar; 140(6):1425-1435. PubMed ID: 27925182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of S100A8 and S100A9 as negative regulators for lymph node metastasis of gastric adenocarcinoma.
    Choi JH; Shin NR; Moon HJ; Kwon CH; Kim GH; Song GA; Jeon TY; Kim DH; Kim DH; Park DY
    Histol Histopathol; 2012 Nov; 27(11):1439-48. PubMed ID: 23018243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Over-expression of 14-3-3sigma in budding colorectal cancer cells modulates cell migration in the presence of tenascin-C.
    Ide M; Saito K; Tsutsumi S; Tsuboi K; Yamaguchi S; Asao T; Kuwano H; Nakajima T
    Oncol Rep; 2007 Dec; 18(6):1451-6. PubMed ID: 17982629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage mannose receptor 1 and S100A9 were identified as serum diagnostic biomarkers for colorectal cancer through a label-free quantitative proteomic analysis.
    Fan NJ; Chen HM; Song W; Zhang ZY; Zhang MD; Feng LY; Gao CF
    Cancer Biomark; 2016; 16(2):235-43. PubMed ID: 26682511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal Cancer Cell Line Proteomes Are Representative of Primary Tumors and Predict Drug Sensitivity.
    Wang J; Mouradov D; Wang X; Jorissen RN; Chambers MC; Zimmerman LJ; Vasaikar S; Love CG; Li S; Lowes K; Leuchowius KJ; Jousset H; Weinstock J; Yau C; Mariadason J; Shi Z; Ban Y; Chen X; Coffey RJC; Slebos RJC; Burgess AW; Liebler DC; Zhang B; Sieber OM
    Gastroenterology; 2017 Oct; 153(4):1082-1095. PubMed ID: 28625833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annexin II overexpression correlates with stromal tenascin-C overexpression: a prognostic marker in colorectal carcinoma.
    Emoto K; Yamada Y; Sawada H; Fujimoto H; Ueno M; Takayama T; Kamada K; Naito A; Hirao S; Nakajima Y
    Cancer; 2001 Sep; 92(6):1419-26. PubMed ID: 11745218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization.
    O'Connell JT; Sugimoto H; Cooke VG; MacDonald BA; Mehta AI; LeBleu VS; Dewar R; Rocha RM; Brentani RR; Resnick MB; Neilson EG; Zeisberg M; Kalluri R
    Proc Natl Acad Sci U S A; 2011 Sep; 108(38):16002-7. PubMed ID: 21911392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer.
    Galván JA; Helbling M; Koelzer VH; Tschan MP; Berger MD; Hädrich M; Schnüriger B; Karamitopoulou E; Dawson H; Inderbitzin D; Lugli A; Zlobec I
    Oncotarget; 2015 Jan; 6(2):874-85. PubMed ID: 25528769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of CXCR4 and SDF1 as prognostic factors for survival and the association with clinicopathology in colorectal cancer: A systematic meta-analysis.
    Li YP; Pang J; Gao S; Bai PY; Wang WD; Kong P; Cui Y
    Tumour Biol; 2017 Jun; 39(6):1010428317706206. PubMed ID: 28621237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive fluorogenic derivatization-liquid chromatography/tandem mass spectrometry proteomic analysis of colorectal cancer cell to identify biomarker candidate.
    Koshiyama A; Ichibangase T; Imai K
    Biomed Chromatogr; 2013 Apr; 27(4):440-50. PubMed ID: 22991145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphovascular invasion of colorectal cancer is correlated to SPARC expression in the tumor stromal microenvironment.
    Yoshimura T; Nagahara M; Kuo C; Turner RR; Soon-Shiong P; Hoon DS
    Epigenetics; 2011 Aug; 6(8):1001-11. PubMed ID: 21725199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
    Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
    Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of nemo-like kinase is an independent prognostic factor in colorectal cancer.
    Zhang W; He J; Du Y; Gao XH; Liu Y; Liu QZ; Chang WJ; Cao GW; Fu CG
    World J Gastroenterol; 2015 Aug; 21(29):8836-47. PubMed ID: 26269673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic analysis shows down-regulations of cytoplasmic carbonic anhydrases, CAI and CAII, are early events of colorectal carcinogenesis but are not correlated with lymph node metastasis.
    Wang N; Chen Y; Han Y; Zhao Y; Liu Y; Guo K; Jiang Y
    Tumori; 2012 Nov; 98(6):783-91. PubMed ID: 23389367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.